¼¼°èÀÇ µðÁöÅÐ PCR ½ÃÀå
Digital PCRs
»óǰÄÚµå : 1545523
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

µðÁöÅÐ PCR ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 3¾ï 7,120¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 2¾ï 1,720¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â µðÁöÅÐ PCR ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.0% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 3¾ï 7,120¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ±âÃÊ ¿¬±¸ ÀÀ¿ë ºÐ¾ß´Â CAGR 8.0%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 1¾ï 5,070¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÓ»ó Áø´Ü ÀÀ¿ë ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 8.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 5,980¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»ó

¹Ì±¹ µðÁöÅÐ PCR ½ÃÀå ±Ô¸ð´Â 2023³â 5,980¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 5,670¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â ºÐ¼® ±â°£ µ¿¾È 7.3%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 7.3%¿Í 6.5%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¾à 6.4%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è µðÁöÅÐ PCR ½ÃÀå µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

µðÁöÅÐ PCRÀ̶õ ¹«¾ùÀ̸ç, ¿Ö ºÐÀÚ»ý¹°ÇÐÀÇ °ÔÀÓ Ã¼ÀÎÀúÀΰ¡?

µðÁöÅÐ PCR(dPCR)Àº DNA ¶Ç´Â RNA¸¦ Á¤·®È­Çϰí ÁõÆøÇÏ´Â µ¥ »ç¿ëµÇ´Â °íÁ¤¹Ð, °í°¨µµ ºÐÀÚ ±â¼úÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀº »ùÇÃÀ» ¿©·¯ °³ÀÇ °³º° ¹ÝÀÀÀ¸·Î ºÐÇÒÇϰí, PCR ÁõÆø ÈÄ °¢ ºÐÇÒÀ» ºÐ¼®ÇÏ¿© Ç¥Àû ¼­¿­ÀÇ À¯¹«¸¦ °áÁ¤ÇÏ¿© ±âÁ¸ PCR ¹æ¹ýº¸´Ù ´õ Á¤È®ÇÑ Á¤·®À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. µðÁöÅÐ PCRÀº ÂüÁ¶ Ç¥ÁØÀ̳ª ³»ºÎ ´ëÁ¶±º ¾øÀ̵µ Àý´ëÀûÀÎ Á¤·®À» Á¦°øÇϹǷΠÀú³óµµ Ç¥Àû °ËÃâ, À¯ÀüÀÚ ¹ßÇö ¼öÁØ Æò°¡, À¯ÀüÀû µ¹¿¬º¯ÀÌ ºÐ¼® µîÀÇ ½Å·Ú¼ºÀÌ Å©°Ô Çâ»óµË´Ï´Ù. ÀÌ ±â¼úÀº Á¤È®ÇÑ ÃøÁ¤ÀÌ Áß¿äÇÑ ÀÓ»ó Áø´Ü, ¸ÂÃã ÀÇ·á ¹× È¯°æ »ý¹°Çп¡¼­ ƯÈ÷ °¡Ä¡°¡ ³ô½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº µðÁöÅÐ PCRÀÇ ´É·ÂÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

µðÁöÅÐ PCRÀÇ ÃÖ±Ù ±â¼ú ¹ßÀü¿¡´Â À¯Ã¼¿ªÇÐ, ¹Ì¼¼À¯Ã¼°øÇÐ ¹× ¼ÒÇÁÆ®¿þ¾î ºÐ¼®ÀÇ °³¼±ÀÌ Æ÷ÇԵǾî ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ Á¤È®¼º, »ç¿ë ÆíÀǼº ¹× 󸮷®À» Çâ»ó½ÃÄ×½À´Ï´Ù. ¾×Àû µðÁöÅÐ PCR(ddPCR) ¹× Ĩ ±â¹Ý dPCR°ú °°Àº Çõ½ÅÀº ºÐ¼®ÇÒ ÆÄƼ¼ÇÀÇ ¼ö¸¦ Áõ°¡½ÃÅ´À¸·Î½á ´õ ³ôÀº °¨µµ¿Í Á¤È®µµ¸¦ Á¦°øÇÏ¿© ÀÌ ºÐ¾ß¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ» ÅëÇØ ¿¬±¸ÀÚµéÀº Ç÷¾× »ùÇÃÀÇ Àú³óµµ Á¾¾ç DNA¿Í °°Àº Èñ±ÍÇÑ DNA Ç¥ÀûÀ» Àü·Ê ¾ø´Â Á¤È®µµ·Î °ËÃâÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÀÚµ¿È­ ¹× ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼® ¼ÒÇÁÆ®¿þ¾îÀÇ ÅëÇÕÀº ÀÎÀû ¿À·ù °¡´É¼ºÀ» ÁÙÀÌ°í ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ¿© µðÁöÅÐ PCRÀ» °í󸮷® ȯ°æ¿¡¼­ ÀÏ»óÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ´Â °ß°íÇÑ µµ±¸·Î ¸¸µé¾îÁÝ´Ï´Ù.

µðÁöÅÐ PCR ±â¼úÀÌ ÁÖµµÇÏ´Â ÀÀ¿ë ºÐ¾ß´Â ¹«¾ùÀϱî?

µðÁöÅÐ PCRÀº ±âÃÊ ¿¬±¸¸¦ ³Ñ¾î ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼­ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÓ»ó Áø´Ü¿¡¼­´Â ¾Ï µ¹¿¬º¯ÀÌ ¹× °¨¿°ÀÇ Á¶±â ¹ß°ß, ÃÖ¼Ò ÀÜÁ¸ Áúȯ ¸ð´ÏÅ͸µ, Ä¡·á È¿°ú ÃßÀû µî¿¡ »ç¿ëµÇ¾î ȯÀÚÀÇ Ä¡·á °èȹ°ú °á°ú¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ȯ°æ ¸ð´ÏÅ͸µ ºÐ¾ß¿¡¼­ dPCRÀº Åä¾ç°ú ¹° »ùÇÿ¡¼­ ³·Àº ¼öÁØÀÇ º´¿ø±Õ°ú À¯ÀüÀÚ º¯Çü ÀÛ¹°À» °ËÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºü¸£°Ô ¼ºÀåÇÏ´Â ¾×ü »ý°Ë ºÐ¾ß¿¡¼­ dPCRÀº ¼øÈ¯ Á¾¾ç DNAÀÇ °ËÃâ ¹× Á¤·®È­¸¦ ÅëÇØ ºñħ½ÀÀû ¾Ï Áø´Ü¿¡ µµ¿òÀ» ÁÖ¸ç, Á¶±â Áø´Ü, ¿¹ÈÄ ¿¹Ãø ¹× Áúº´ ¸ð´ÏÅ͸µÀ» À§ÇÑ °­·ÂÇÑ µµ±¸¸¦ Á¦°øÇÕ´Ï´Ù. °¢ ÀÀ¿ë ºÐ¾ß´Â dPCRÀÇ ³ôÀº ¹Î°¨µµ¿Í ³ôÀº Á¤È®µµÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Áß¿äÇÑ ¿¬±¸ ¹× ÀÀ¿ë ºÐ¾ß·ÎÀÇ ÅëÇÕÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ PCR ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

µðÁöÅÐ PCR ½ÃÀåÀÇ ¼ºÀåÀº °ß°íÇÑ Á¤·®È­ ±â¼úÀ» ÇÊ¿ä·Î ÇÏ´Â Á¤È®ÇÑ ºÐÀÚÁø´Ü°ú °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ Æ÷ÇÔÇÑ ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÉ °ÍÀÔ´Ï´Ù. À¯ÀüÀÚ Áúȯ°ú ¾ÏÀÇ À¯º´·ü Áõ°¡´Â ¾×ü »ý°Ë¿¡ ´ëÇÑ Àνİú ÀÓ»ó äÅà Áõ°¡¿Í ÇÔ²² µðÁöÅÐ PCR ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, dPCR ¼³Á¤ÀÇ È¿À²¼ºÀ» ³ôÀÌ°í ºñ¿ëÀ» Àý°¨ÇÏ´Â ±â¼ú Çõ½Åµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Äǰ ¾ÈÀü, ȯ°æ ¸ð´ÏÅ͸µ ¹× ³ó¾÷ »ý¹°Çп¡¼­ dPCRÀÇ Àû¿ë ¹üÀ§°¡ ³Ð¾îÁü¿¡ µû¶ó dPCRÀÇ ´ÙÀç´Ù´ÉÇÔ°ú À¯È¿¼ºÀÌ °­Á¶µÇ¾î ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ÅõÀÚ¸¦ À¯Ä¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº µðÁöÅÐ PCR ½Ã½ºÅÛÀÇ Áö¼ÓÀûÀÎ °³¼±°ú Á¤¹Ð Áø´Ü¿¡ ´ëÇÑ °­Á¶¿Í ÇÔ²² ºÐÀÚ»ý¹°ÇÐ ¹× ÀÓ»ó Áø´ÜÀÇ ¹Ì·¡¿¡ ´ëÇÑ Á߿伺À» ¹Ý¿µÇÏ¿© dPCR ½ÃÀåÀÌ Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀÓÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 46°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital PCRs Market to Reach US$371.2 Million by 2030

The global market for Digital PCRs estimated at US$217.2 Million in the year 2023, is expected to reach US$371.2 Million by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Basic Research Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$150.7 Million by the end of the analysis period. Growth in the Clinical Diagnostics Application segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$59.8 Million While China is Forecast to Grow at 7.3% CAGR

The Digital PCRs market in the U.S. is estimated at US$59.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$56.7 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Digital PCRs Market - Key Trends and Drivers Summarized

What Is Digital PCR and Why Is It a Game-Changer in Molecular Biology?

Digital PCR (dPCR) is a highly precise and sensitive molecular technique used to quantify and amplify DNA or RNA. This method partitions a sample into many individual reactions. After PCR amplification, each partition is analyzed to determine the presence or absence of the target sequence, allowing for more accurate quantification than traditional PCR methods. Digital PCR provides absolute quantification without the need for reference standards or internal controls, which significantly enhances its reliability for detecting low-abundance targets, assessing gene expression levels, and analyzing genetic variations. This technology is particularly valuable in clinical diagnostics, personalized medicine, and environmental biology, where precise measurements are crucial.

How Are Technological Advancements Refining Digital PCR Capabilities?

Recent technological advancements in digital PCR include improvements in fluid dynamics, microfluidics, and software analytics, which enhance the accuracy, usability, and throughput of these systems. Innovations such as droplet digital PCR (ddPCR) and chip-based dPCR have revolutionized the field by increasing the number of partitions analyzed, thereby providing greater sensitivity and precision. These advancements allow researchers to detect rare DNA targets, such as low-abundance tumor DNA in blood samples, with unprecedented accuracy. Furthermore, the integration of automation and real-time data analysis software reduces the potential for human error and streamlines the workflow, making digital PCR a robust tool for routine use in high-throughput settings.

What Applications Are Driven by Digital PCR Technology?

Digital PCR is becoming increasingly crucial across various applications beyond basic research. In clinical diagnostics, it is used for early detection of cancer mutations and infectious diseases, monitoring minimal residual disease, and tracking treatment efficacy, which can directly influence patient treatment plans and outcomes. In the field of environmental monitoring, dPCR enables the detection of low-levels of pathogens or GMOs in soil and water samples. Additionally, in the burgeoning field of liquid biopsy, dPCR helps in non-invasive cancer diagnostics by detecting and quantifying circulating tumor DNA, offering a powerful tool for early diagnosis, prognosis, and disease monitoring. Each application benefits from dPCR’s high sensitivity and precision, driving its integration into these critical areas of study and application.

What Drives the Growth in the Digital PCR Market?

The growth in the digital PCR market is driven by several factors, including the increasing demand for precise molecular diagnostics and personalized medicine, which require robust quantitative techniques. The rising prevalence of genetic disorders and cancer, coupled with growing awareness and clinical adoption of liquid biopsies, further fuels the demand for digital PCR technology. Technological innovations that enhance the efficiency and reduce the cost of dPCR setups also contribute to market expansion. Additionally, the broadening applications of dPCR in food safety, environmental monitoring, and agricultural biology emphasize its versatility and effectiveness, attracting investment from various sectors. These factors, combined with the ongoing improvements in digital PCR systems and a growing emphasis on precision diagnostics, ensure that the market for dPCR will continue to expand, reflecting its critical importance in the future of molecular biology and clinical diagnostics.

Select Competitors (Total 46 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â